Amgen Criticizes Draft Report Before Publication

Amgen is criticizing ICER’s assessments in a recent draft report that hasn’t even been published yet. Find out more here. (Source: Jaimy Lee, MM&M, 4/5/16)

You might also be interested in:

PAI and BresMed Join Forces to Support Expanded Use of More… 07/22/2019
Real World Data and Evidence: Payer Insights 09/26/2019
CMS Chief Criticizes High Launch Prices 12/02/2019
Leveraging Technology to Reduce Costs in Clinical Trials 06/30/2019
NPC Disputes ICER Report on Unjustified Price Hikes 10/08/2019
Evolving Health Economy Puts More Emphasis on Strategy Leaders 11/23/2019
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020